Related Experiment Videos
Bacterial meningitis: an update
1Infectious Disease Division, Cook-Fort Worth Children's Medical Center, Texas.
Abstract:
Antibiotics and improvements in supportive care have greatly reduced the mortality from bacterial meningitis. Nevertheless, the incidence of neurodevelopmental sequelae remains unacceptably high. Ampicillin and chloramphenicol remain the standard for antimicrobial therapy against which other agents must be compared. A number of adjunct therapies are being investigated for their possible effectiveness in reducing hearing loss and other neurologic effects of this disease. There continues to be a need for carefully performed follow-up studies to assess any possible benefit of these agents. A significant percentage of children surviving an episode of bacterial meningitis have obvious or subtle neurodevelopmental deficits. The role of the pediatric neurologist should not end with management of acute problems such as seizures but should be expanded to aid in close developmental monitoring of these high-risk children.
Insights
Bacterial meningitis survival is improving, but many children still face neurodevelopmental deficits. Further research is needed on adjunctive therapies to prevent long-term effects and guide pediatric neurologist care.
Area of Science:
- Pediatric neurology
- Infectious diseases
- Neurodevelopmental disorders
Background:
- Bacterial meningitis mortality has decreased due to antibiotics and supportive care.
- Significant neurodevelopmental sequelae persist in survivors.
- Ampicillin and chloramphenicol are standard treatments.
Purpose of the Study:
- Evaluate adjunct therapies for reducing hearing loss and neurologic deficits in bacterial meningitis.
- Highlight the need for follow-up studies on potential benefits of new treatments.
- Emphasize the expanded role of pediatric neurologists in developmental monitoring.
Main Methods:
- Review of current therapeutic standards and ongoing investigations.
- Analysis of the incidence and nature of neurodevelopmental sequelae.
- Discussion of the necessity for long-term developmental monitoring.
Main Results:
- While mortality is reduced, neurodevelopmental deficits remain a significant concern.
- Adjunct therapies are under investigation for their potential to mitigate long-term effects.
- Current evidence necessitates further rigorous follow-up studies.
Conclusions:
- Pediatric neurologists must extend their role beyond acute care to include developmental surveillance.
- Continued research into adjunct therapies is crucial for improving outcomes.
- Addressing neurodevelopmental deficits is key to reducing the long-term burden of bacterial meningitis.